ArticleThe Journal of biological chemistry2011

In vitro and in vivo anticancer activity of a synthetic glycolipid as Toll-like receptor 4 (TLR4) activator.

Yong-Shiang Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.